お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:シングルセシングルセルゲノミクスの世界市場・COVID-19の影響 (2021-2025年):エンドユーザー・技術別
市場調査レポート
商品コード
996941

シングルセシングルセルゲノミクスの世界市場・COVID-19の影響 (2021-2025年):エンドユーザー・技術別

Single Cell Genomics Markets Forecasts by End User & Technology. With Executive and Consultant Guides and including Customized Forecasting and Analysis. With COVID Updates. 2021 to 2025

出版日: | 発行: Howe Sound Research | ページ情報: 英文 270 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.15円
シングルセシングルセルゲノミクスの世界市場・COVID-19の影響 (2021-2025年):エンドユーザー・技術別
出版日: 2021年03月23日
発行: Howe Sound Research
ページ情報: 英文 270 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

シングルセルゲノミクスは、科学研究開発の柱として台頭しており、医療のあらゆる面で応用が可能です。特に免疫・腫瘍学や微生物学に関連した新しい臨床分野に適用されつつあります。一方、シングルセルゲノミクスの最大の市場は依然として研究分野であり、ゲノミクスへの理解が進み、新しいバイオテクノロジーの分野が切り開かれるなかで、活況を呈しています。

当レポートでは、世界のシングルセルゲノミクスの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、技術の種類と概要、市場規模の推移・予測、技術・エンドユーザー・地域別の内訳、企業間の各種展開、主要企業のプロファイルなどをまとめています。

マーケットガイド

第1章 イントロダクション・市場の定義

第2章 技術ガイド

  • 単一細胞分離
  • 増幅
  • PCR
  • NGS
  • マイクロアレイ
  • デジタル空間プロファイリング(DSP)技術

第3章 産業概要

  • 主な参入企業

第4章 市場動向

  • 成長推進因子
  • 成長抑制因子
  • 技術開発

第5章 近年の展開

第6章 主要企業のプロファイル

  • 10x Genomics
  • 1CellBio
  • Agilent
  • Beckman Coulter
  • Becton Dickinson
  • Bio-Rad
  • Bitbiome
  • Bruker
  • Cell Microsystems
  • Cellsee Diagnostics
  • CellSorter
  • Cytena
  • CytoTrack
  • Dolomite Bio
  • Fluidigm
  • Fluxion Biosciences
  • Illumina
  • IncellDx
  • Labcyte
  • Leica Microsystems
  • Miltenyi Biotec
  • Mission Bio
  • Oxford Nanopore Technologies
  • NanoString
  • Perkin Elmer
  • Qiagen
  • Readcoor
  • S2 Genomics
  • Silicon Biosystems
  • Singulomics
  • Sony
  • Takara Bio
  • Thermo Fisher
  • Watchmaker Genomics

第7章 世界市場の規模

第8章 市場分析・予測:技術別

  • PCR
  • qPCR
  • NGS
  • マイクロアレイ
  • その他

第9章 市場分析・予測:エンドユーザー別

  • 研究
  • バイオ医薬品
  • 臨床
  • その他

第10章 付録

図表

Table of Tables

  • Table 1 Global List of Gene Sequencing Facilities
  • Table 2 Cell Isolation Overview
  • Table 3 Market Players by Type
  • Table 4 Five Factors Driving Growth
  • Table 5 Three Factors Limiting Growth
  • Table 6 Single Cell Genomics Global Market by Country/Region
  • Table 7 Single Cell Genomics Global Market by Technology
  • Table 8 Global Market End User
  • Table 9 PCR Market by Country
  • Table 10 qPCR Market by Country
  • Table 11 NGS Market by Country
  • Table 12 Microarray Market by Country
  • Table 13 Other Technology Market by Country
  • Table 14 Research Market by Country
  • Table 15 BioPharma Market by Country
  • Table 16 Clinical Market by Country
  • Table 17 Other End User Market by Country

Table of Figures

  • Figure 1 Size of Different Genomes
  • Figure 2 flourescence Activated Sorter
  • Figure 3 Market Size by Country
  • Figure 4 Global Market by Technology - Base vs. Final Year
  • Figure 5 Technology Market Base Year
  • Figure 6 Technology Market Final Year
  • Figure 7 Technology Share by Year
  • Figure 8 Technology Segment Growth
  • Figure 9 End User - Base vs. Final Year
  • Figure 10 End User Market Base Year
  • Figure 11 End User Market Final Year
  • Figure 12 End User Share by Year
  • Figure 13 End User Segment Growth
  • Figure 14 Chart - PCR Market Growth
  • Figure 15 Chart qPCR Market Growth
  • Figure 16 Chart - NGS Market Growth
  • Figure 17 Chart - Microarray Market Growth
  • Figure 18 Chart - Other Technology Market Growth
  • Figure 19 Chart - Research Market Growth
  • Figure 20 Chart - BioPharma Market Growth
  • Figure 21 Chart - Clinical Market Growth
  • Figure 22 Chart - Other End User Market Growth
  • Figure 23 FDA Cancer Drug Approvals by Year
  • Figure 24 Clinical Trials for Immunotherapy by Year
  • Figure 25 Pie Chart of Prevalence of Cancer Treatments
目次

OVERVIEW:

Single Cell Genomics is emerging as a mainstay of scientific research and development. New life forms have already been identified. This means new diseases and new cures. There are applications in every aspect of healthcare. Just coming out of the lab it is finding its footing in new clinical applications especially related to immune-oncology and microbiology. But the largest market is still in research and the market is booming as understanding the genomics of individual cells opens up a whole new world of biotechnology.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

i. Market Guides

  • iA. Situation Analysis & COVID Update
  • iB. Guide for Executives and Marketing Staff
  • iC. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

  • 1.1 What is Single Cell Genomics?
  • 1.2 SCG - Still Early Days
  • 1.3 Market Definition
    • 1.3.1 Market Size
    • 1.3.2 Currency
    • 1.3.3 Years
  • 1.4 Methodology
    • 1.4.1 Authors
    • 1.4.2 Sources
  • 1.5 Sizing the Genome - Not What You Think
    • 1.5.1 Cost, Price and Genome Size, Pricing Practice
  • 1.6 GLOBAL LISTING OF HIGH THROUGHPUT SEQUENCING ESTABLISHMENTS INSTALLED BASE - Location & Contacts

2. Single Cell Genomics - Guide to Technology

  • 2.1 Isolating Single Cells
    • 2.1.1 FACS
    • 2.1.2 LCM
    • 2.1.3 Micromanipulators
    • 2.1.4 Microfluidics
  • 2.2 Amplification
    • 2.2.1 WTA - Whole Transcriptome Amplification
    • 2.2.2 WGA - Whole Genome Amplification
  • 2.3 PCR
  • 2.4 NGS
  • 2.5 Microarray
  • 2.6 Digital Spatial Profiling (DSP) Technology

3. Industry Overview

  • 3.1 Players in a Dynamic Market
    • 3.1.1 Academic Research Lab
    • 3.1.2 Genomic Instrumentation Supplier
    • 3.1.3 Cell Separation and Viewing Instrumentation Supplier
    • 3.1.4 Cell Line and Reagent Supplier
    • 3.1.5 Pharmaceutical or Reagent Company
    • 3.1.6 Audit Body
    • 3.1.7 Certification Body

4. Market Trends

  • 4.1 Factors Driving Growth
    • 4.1.1 Immuno-oncology
    • 4.1.2 Research Range
    • 4.1.3 Technology Maturity & Convergence
    • 4.1.4 Declining Costs
  • 4.2 Factors Limiting Growth
    • 4.2.1 Competition
    • 4.2.2 Instrument Integration
    • 4.2.3 Technology Shift
    • 4.2.4 Technology Limitations
  • 4.3 Technology Development
    • 4.3.1 Spatial Profiling
    • 4.3.2 Integration
    • 4.3.3 Big Data
    • 4.3.4 Kits and Commodities

5. Single Cell Genomics Recent Developments

  • 5.1 Recent Developments - Importance and How to Use This Section
    • 5.1.1 Importance of These Developments
    • 5.1.2 How to Use This Section
      • Parse Biosciences Lowers Cost Barriers to Single-Cell Transcriptomics
      • Deepcell Advancing Tech for Single-Cell Genomics
      • 10x Genomics Outlines 2021 Growth Plans
      • Single-Cell Genomics Firm Analytical Biosciences Inks Deal with BioMap
      • IsoPlexis Features Cheaper, More Flexible Single-Cell Proteomic Systems
      • DNTR-Seq Combines WGS, Transcriptomics in Single Cells
      • BitBiome Builds Single-Cell Bacterial Sequencing Business
      • S2 Genomics Signs Distribution Agreements for Asia-Pacific
      • Single-Cell COVID-19 Study Investigates Immune Hyperactivation
      • Levitas Bio to Launch Magnetic Levitation Cell Separation Platform
      • Single-Cell and Spatial Genomics
      • Single-Cell Genomics
      • Namocell, Takara Bio, HepaTx Partner on Single-Cell Genomics
      • Vizgen Launches With $14M Series A Financing
      • SeqWell Raises $9M in Series B Round
      • MGI Tech Introduces Portable Sequencer, Single-Cell Prep Device
      • Celsius Therapeutics to Use Single-Cell Platform in Immuno-Oncology
      • 10x Genomics Expects $271M In Proceeds
      • Celsius Therapeutics, Janssen Biotech Form Biomarker Discovery Alliance
      • Bio-Rad, 10x Genomics Claim Single-Cell Patent Fight Victories on Different Fronts
      • Bio-Rad Launches its Single Cell scATAC-Seq Solution
      • 10x Genomics Acquires Spatial Transcriptomics
      • Takara Bio strengthens its IP position on single cell RNA-seq
      • Mission Bio Launches Tapestri® for Targeted Single-Cell DNA Custom Panels
      • SingulOmics Detects Somatic Single Nucleotide Variations in Single Cells
      • 1CELLBIO and OMI to validate Single Cell Analysis for Personalized Medicine
      • Sony MA900 Cell Sorter Nominated
      • UNC Cure Center and Cell Microsystems Receive NIH Contract for Single Cell HIV
      • Diagnostic Assay
      • Bio-Rad's dd-PCR tests for leukemia cleared
      • IncellDx's Single Cell Immuno-Oncology/PD-L1 Technology used in new Cancer Assay
      • Cytena GmbH land EUR 3M in Series A
      • NanoString Announces Launch of CAR-T Panel
      • Dolomite Bio launches high throughput single nuclei profiling on Nadia platform
      • Silicon Biosystems Develops New Assay for Circulating Multiple Myeloma Cells

6. Profiles of Key Single Cell Genomics Companies

  • 10x Genomics
  • 1CellBio
  • Agilent
  • Beckman Coulter
  • Becton Dickinson
  • Bio-Rad
  • Bitbiome
  • Bruker
  • Cell Microsystems
  • Cellsee Diagnostics
  • CellSorter
  • Cytena
  • CytoTrack
  • Dolomite Bio
  • Fluidigm
  • Fluxion Biosciences
  • Illumina
  • IncellDx
  • Labcyte
  • Leica Microsystems
  • Miltenyi Biotec
  • Mission Bio
  • Oxford Nanopore Technologies
  • NanoString
  • Perkin Elmer
  • Qiagen
  • Readcoor
  • S2 Genomics
  • Silicon Biosystems
  • Singulomics
  • Sony
  • Takara Bio
  • Thermo Fisher
  • Watchmaker Genomics

7. Single Cell Genomics Global Market Size

  • 7.1 Global Market Overview by Country
    • 7.1.1 Table - Global Market by Country
    • 7.1.2 Chart - Global Market by Country
  • 7.2 Global Market Size by Technology - Overview
    • 7.2.1 Table - Global Market by Technology
    • 7.2.2 Chart - Global Market by Technology - Base/Final Year Comparison
    • 7.2.3 Chart - Global Market by Technology - Base Year
    • 7.2.4 Chart - Global Market by Technology - Final Year
    • 7.2.5 Chart - Global Market by Technology - Share by Year
    • 7.2.6 Chart - Global Market by Technology - Segment Growth
  • 7.3 Global Market End User - Overview
    • 7.3.1 Table - Global Market End User
    • 7.3.2 Chart - Global Market End User - Base/Final Year Comparison
    • 7.3.3 Chart - Global Market End User - Base Year
    • 7.3.4 Chart - Global Market End User - Final Year
    • 7.3.5 Chart - Global Market End User - Share by Year
    • 7.3.6 Chart - Global Market End User - Segment Growth

8. Global Market by Technology

  • 8.1 PCR Market
    • 8.1.1 Table - PCR Market by Country
    • 8.1.2 Chart - PCR Market by Country
  • 8.2 qPCR Market
    • 8.2.1 Table - qPCR Market by Country
    • 8.2.2 Chart - qPCR Market Growth
  • 8.3 NGS Market
    • 8.3.1 Table - NGS Market by Country
    • 8.3.2 Chart - NGS Market Growth
  • 8.4 Microarray Market
    • 8.4.1 Table - Microarray Market by Country
    • 8.4.2 Chart - Microarray Market Growth
  • 8.5 Other Technology Market
    • 8.5.1 Table - Other Technology Market by Country
    • 8.5.2 Chart - Other Technology Market Growth

9. Single Cell Genomics Market by End User

  • 9.1 Research Market
    • 9.1.1 Table - Research Market by Country
    • 9.1.2 Chart - Research Market Growth
  • 9.2 BioPharma Market
    • 9.2.1 Table - BioPharma Market by Country
    • 9.2.2 Chart - BioPharma Market Growth
  • 9.3 Clinical Market
    • 9.3.1 Table - Clinical Market by Country
    • 9.3.2 Chart - Clinical Market Growth
  • 9.4 Other End User Market
    • 9.4.1 Table - Other End User Market by Country
    • 9.4.2 Chart - Other End User Market Growth

10. Appendices

  • 10.1 FDA Cancer Drug Approvals by Year
  • 10.2 Clinical Trials Started 2010 to 2016
  • 10.3 Prevalence of Cancer Treatments
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.